compounded semaglutide not losing weight Why Am I on Semaglutide? Why Am I Not Losing

The two share the same three peptides at identical doses, so switching mid-cycle is a vial swap

C., Bray, G

Glucagon-like peptide-1 inhibits pancreatic ATP-sensitive potassium channels via a protein kinase A- and ADP-dependent mechanism

The expected timeline: Phase 3 trials completing: Results rolling out throughout the rest of this year FDA submission: Expected sometime after full Phase 3 data is available Potential FDA approval: Estimated for late 2027 at the earliest Commercial availability: If approved, launch would follow in 2027-2028 For those tracking retatrutide availability updates , the situation is evolving

Weight tends to rebound

However, this does not mean your face will permanently look as severe as it does at the peak of your weight loss